Showing results (131-140 of 351) with videos related to

Sort By:
Pageof 36
Hepatology Communications|January 8, 2020
Circulating MicroRNA-122 and Fibrosis Stage Predict Mortality of Japanese Patients With Histopathologically Confirmed NAFLDNorio Akuta, Yusuke Kawamura, Yasuji Arase, et al.
Oncology|September 30, 2020
TERT Promoter Mutation in Serum Cell-Free DNA Is a Diagnostic Marker of Primary Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver DiseaseNorio Akuta, Yusuke Kawamura, Mariko Kobayashi, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2019
Impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analoguesTetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, et al.
Liver Cancer|November 30, 2018
Effectiveness of Particle Radiotherapy in Various Stages of Hepatocellular Carcinoma: A Pilot StudyYushi Sorin, Kenji Ikeda, Yusuke Kawamura, et al.
Journal of Medical Virology|July 1, 2016
Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in JapanNorio Akuta, Hitomi Sezaki, Fumitaka Suzuki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 19, 2024
Etiological changes of liver cirrhosis and hepatocellular carcinoma-complicated liver cirrhosis in Japan: Updated nationwide survey from 2018 to 2021Hirayuki Enomoto, Norio Akuta, Hayato Hikita, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 5, 2010
New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinomaYusuke Kawamura, Kenji Ikeda, Miharu Hirakawa, et al.
The American Journal of Medicine|October 6, 2010
Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C patientsYusuke Kawamura, Yasuji Arase, Kenji Ikeda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 31, 2018
Recurrence rates of pruritus after the stop of nalfurafine hydrochloride in chronic liver disease: Preliminary prospective confirmatory trialNorio Akuta, Hiromitsu Kumada, Shunichiro Fujiyama, et al.
Oncology|June 29, 2011
Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinomaNorihiro Imai, Kenji Ikeda, Yuya Seko, et al.
Pageof 36